Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas”

1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,756
Index total 30,257
Page 67 / 74

Quick answer

This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,756 results for “The Board of Regents of the University of Texas” · 30,257 patents in full index Clear search

  1. US 6676941

    Antibody conjugate formulations for selectively inhibiting VEGF

    The Board of Regents of the University of Texas System · Granted Jan 13, 2004 · Expires Jan 8, 2024

    expired

  2. US 6673768

    Transgenic animal models for cardiac hypertrophy and methods of use thereof (treating)

    The Board of Regents of the University of Texas System · Granted Jan 6, 2004 · Expires Jan 1, 2024

    expired

  3. US 6656471

    HIV-specific T-cell induction

    The Board of Regents of the University of Texas System · Granted Dec 2, 2003 · Expires Nov 27, 2023

    expired

  4. US 6653351

    Adjuvant chemotherapy for anaplastic gliomas

    The Board of Regents of the University of Texas System · Granted Nov 25, 2003 · Expires Nov 20, 2023

    expired

  5. US 6649631

    Compositions and methods for treating bone deficit conditions

    The Board of Regents of the University of Texas System · Granted Nov 18, 2003 · Expires Nov 13, 2023

    expired

  6. US 6649593

    Modulators of SREBP processing

    The Board of Regents of the University of Texas System · Granted Nov 18, 2003 · Expires Nov 13, 2023

    expired

  7. US 6632626

    Methods of assaying farnesyl transferase

    The Board of Regents of the University of Texas System · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired

  8. US 6632446

    Coating substrates by polymerizing macromers having free radical-polymerizable substituents

    The Board of Regents of the University of Texas System · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired

  9. US 6632628

    Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression

    The Board of Regents of the University of Texas System · Granted Oct 14, 2003 · Expires Oct 9, 2023

    expired

  10. US 6630572

    Thrombin derived polypeptides: compositions and methods for use

    The Board of Regents of the University of Texas System · Granted Oct 7, 2003 · Expires Oct 2, 2023

    expired

  11. US 6630170

    Mesoporous compositions and method of preparation

    The Board of Regents of the University of Texas System · Granted Oct 7, 2003 · Expires Oct 2, 2023

    expired

  12. US 6627731

    Thrombin derived polypeptides; compositions and methods for use

    The Board of Regents of the University of Texas System · Granted Sep 30, 2003 · Expires Sep 25, 2023

    expired

  13. US 6627189

    Inhibition of cellular proliferation using ras antisense molecules

    The Board of Regents of the University of Texas System · Granted Sep 30, 2003 · Expires Sep 25, 2023

    expired

  14. US 6623957

    Secretion of T cell receptor fragments from recombinant host cells

    The Board of Regents of the University of Texas System · Granted Sep 23, 2003 · Expires Sep 18, 2023

    expired

  15. US 6617441

    Diagnostic test for borrelia infection

    The Board of Regents of the University of Texas · Granted Sep 9, 2003 · Expires Sep 4, 2023

    expired

  16. US 6613757

    COMBINATION OF PROSTACYCLIN WITH AN ESTROGEN OR PROGESTIN FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROTIC VASCULAR DISEASE INCLUDING PREECLAMPSIA AND FOR THE TREATMENT OF HYPERTENSION, AND FOR HORMONE REPLACEMENT THERAPY

    The Board of Regents of the University of Texas System · Granted Sep 2, 2003 · Expires Aug 28, 2023

    expired

  17. US 6608026

    Apoptotic compounds

    The Board of Regents of the University of Texas System · Granted Aug 19, 2003 · Expires Aug 14, 2023

    expired

  18. US 6602975

    Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers

    The Board of Regents of the University of Texas System · Granted Aug 5, 2003 · Expires Jul 31, 2023

    expired

  19. US 6596296

    Drug releasing biodegradable fiber implant

    The Board of Regents of the University of Texas System · Granted Jul 22, 2003 · Expires Jul 17, 2023

    expired

  20. US 6593306

    Methods for modulation and inhibition of telomerase

    The Board of Regents of the University of Texas System · Granted Jul 15, 2003 · Expires Jul 10, 2023

    expired

  21. US 6586242

    TAO protein kinases and methods of use therefor

    The Board of Regents of the University of Texas System · Granted Jul 1, 2003 · Expires Jun 26, 2023

    expired

  22. US 6582725

    Human PEA3 is a tumor suppressor for cancer cells

    The Board of Regents of the University of Texas System · Granted Jun 24, 2003 · Expires Jun 19, 2023

    expired

  23. US 6579893

    Use of troglitazone and related compounds for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jun 17, 2003 · Expires Jun 12, 2023

    expired

  24. US 6576264

    Insoluble drug delivery

    The Board of Regents of the University of Texas System · Granted Jun 10, 2003 · Expires Jun 5, 2023

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.